![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Ardena acquires Syntagon and strengthens API offering
Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of...
Sterling Pharma Solutions experiences record US growth
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has more than doubled its...
MIMETAS Secures 20 Million Dollar Series B Financing
MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing...
Tracelink Global Drug Supply Report 2017
TraceLink’s Global Drug Supply, Safety and Traceability Report survey highlights a lack...
Takeda Statement Regarding Shire plc
Takeda Pharmaceutical Company Limited notes the share price movement with respect to Shire plc. ...
LANXESS posts record earnings for 2017 and a good start to the new fiscal...
Sales up 25.5 percent to EUR 9.66 billion in fiscal year 2017 Strong volume...
TxCell 2017 financial results and 2018 objectives
TxCell SA , a developer of cellular immunotherapies based on regulatory T cells (Tregs) for...
Ardena acquires ChemConnection adding API expertise
Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection, a leading contract manufacturer of...
Sessa Capital Im LP decline Its Bristol Myers Squibb Co (BMY) Position by $272.76...
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2....
The Flatiron Health Acquisitio could make things better For Roche’s Oncology Real-World Evidence Needs
Why Roche paid $1.9 billion for a 5-year-old companyEarlier this month, Roche, a global pharmaceutical...